Journal Title
CURRENT DRUG TARGETS

CURR DRUG TARGETS

ISSN / eISSN
1389-4501 / 1873-5592
Aims and Scope
Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes.

Current Drug Targets publishes guest edited thematic issues written by leaders in the field covering a range of current topics of drug targets. The journal also accepts for publication mini- & full-length review articles and drug clinical trial studies.

As the discovery, identification, characterization and validation of novel human drug targets for drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.
Subject Area

PHARMACOLOGY & PHARMACY

CiteScore
6.40 View Trend
CiteScore Ranking
Category Quartile Rank
Pharmacology, Toxicology and Pharmaceutics - Pharmacology Q2 #99/301
Pharmacology, Toxicology and Pharmaceutics - Drug Discovery Q2 #61/156
Pharmacology, Toxicology and Pharmaceutics - Clinical Biochemistry Q2 #45/113
Pharmacology, Toxicology and Pharmaceutics - Molecular Medicine Q2 #80/171
Web of Science Core Collection
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
Category (Journal Citation Reports 2023) Quartile
PHARMACOLOGY & PHARMACY - SCIE Q3
H-index
92
Country/Area of Publication
NETHERLANDS
Publisher
Bentham Science Publishers B.V.
Publication Frequency
Bimonthly
Year Publication Started
2000
Annual Article Volume
100
Open Access
NO
Contact
BENTHAM SCIENCE PUBL LTD, EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, SHARJAH, U ARAB EMIRATES, 1200 BR

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started